phosphatidylcholines has been researched along with Depression, Involutional in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Aukema, H; Edel, AL; Meek, BP; Modirrousta, M; Ravandi, A; Solati, Z; Stirton, H; Surendran, A | 1 |
Almasy, L; Blangero, J; Curran, JE; Duggirala, R; Glahn, DC; Göring, HHH; Huynh, K; Knowles, EEM; Mathias, SR; Meikle, PJ; Olvera, RL | 1 |
Connemann, BJ; Dreyhaupt, J; Freudenmann, RW; Gahr, M; Kassubek, J; Kregel, T; Pinkhardt, EH; Schmidt, A; Schönfeldt-Lecuona, C | 1 |
Schrappe, O | 1 |
4 other study(ies) available for phosphatidylcholines and Depression, Involutional
Article | Year |
---|---|
Oxolipidomics profile in major depressive disorder: Comparing remitters and non-remitters to repetitive transcranial magnetic stimulation treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Oxidative Stress; Oxylipins; Phosphatidylcholines; Transcranial Magnetic Stimulation; Treatment Outcome | 2021 |
The lipidome in major depressive disorder: Shared genetic influence for ether-phosphatidylcholines, a plasma-based phenotype related to inflammation, and disease risk.
Topics: Adult; Aged; Aged, 80 and over; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Pedigree; Phenotype; Phosphatidylcholines | 2017 |
Retinal changes in patients with major depressive disorder - A controlled optical coherence tomography study.
Topics: Adult; Case-Control Studies; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Phosphatidylcholines; Pyrenes; Retina; Tomography, Optical Coherence | 2018 |
[Studies on the correlation between cerebrospinal fluid lipids and serum lipids].
Topics: Brain Diseases; Cholesterol; Depressive Disorder, Major; Humans; Lipids; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Schizophrenia; Sphingomyelins; Triglycerides | 1972 |